会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 52. 发明申请
    • ENHANCED TRANSPORT USING MEMBRANE DISRUPTIVE AGENTS
    • 使用薄膜破坏剂加强运输
    • US20110288238A1
    • 2011-11-24
    • US13182756
    • 2011-07-14
    • Allan S. HoffmanPatrick StaytonOliver W. PressNiren MurthyChantal Lackey ReedLawrence A. CrumPierre D. MouradTyrone M. PorterDavid Tirrell
    • Allan S. HoffmanPatrick StaytonOliver W. PressNiren MurthyChantal Lackey ReedLawrence A. CrumPierre D. MouradTyrone M. PorterDavid Tirrell
    • C08F220/06C08F265/02C08F299/00
    • A61K47/481A61K41/0028A61K41/0047A61K47/48376A61K47/6801
    • Compositions and methods for transport or release of therapeutic and diagnostic agents or metabolites or other analytes from cells, compartments within cells, or through cell layers or barriers are described. The compositions include a membrane barrier transport enhancing agent and are usually administered in combination with an enhancer and/or exposure to stimuli to effect disruption or altered permeability, transport or release. In a preferred embodiment, the compositions include compounds which disrupt endosomal membranes in response to the low pH in the endosomes but which are relatively inactive toward cell membranes, coupled directly or indirectly to a therapeutic or diagnostic agent. Other disruptive agents can also be used, responsive to stimuli and/or enhancers other than pH, such as light, electrical stimuli, electromagnetic stimuli, ultrasound, temperature, or combinations thereof. The compounds can be coupled by ionic, covalent or H bonds to an agent to be delivered or to a ligand which forms a complex with the agent to be delivered. Agents to be delivered can be therapeutic and/or diagnostic agents. Treatments which enhance delivery such as ultrasound, iontopheresis, and/or electrophoresis can also be used with the disrupting agents.
    • 描述了用于从细胞,细胞内的细胞室或通过细胞层或屏障转运或释放治疗和诊断试剂或代谢物或其它分析物的组合物和方法。 组合物包括膜屏障转运增强剂,并且通常与增强剂和/或暴露于刺激物一起施用以实现破坏或改变渗透性,运输或释放。 在优选的实施方案中,组合物包括响应于内体中的低pH而破坏内体膜的化合物,但是与细胞膜相对无活性的化合物,直接或间接地与治疗剂或诊断剂偶联。 还可以使用其它破坏剂,对除了pH之外的刺激和/或增强剂如光,电刺激,电磁刺激,超声波,温度或其组合都有反应。 这些化合物可以通过离子,共价键或H键连接到待递送的试剂上,或者与配制剂形成配合物。 待递送的药剂可以是治疗和/或诊断剂。 增强递送的治疗如超声波,离子分离和/或电泳也可与破坏剂一起使用。
    • 55. 发明授权
    • Immobilized biomolecules and method of making same
    • 固定生物分子及其制备方法
    • US5034428A
    • 1991-07-23
    • US348049
    • 1989-05-04
    • Allan S. HoffmanLiang C. Dong
    • Allan S. HoffmanLiang C. Dong
    • C12N11/02G01N33/543G01N33/545
    • G01N33/54393C12N11/02G01N33/545G01N2650/00
    • A method of biomolecule immobilization is described in which the biomolecule itself or, alternatively, a monomer-conjugated biomolecule, is grafted with free monomer onto a hydrophilic, solid-phase, polymeric substrate which has been pre-irradiated with ionizing radiation. The pre-irradiation step is carried out, preferably at -78.degree. C. in air, while the grafting step is carried out at 0.degree. C. in a substantially oxygen-free atmosphere. The technique is applicable to immobilization of a wide variety of biomolecules, such as enzymes, catalysts, hormones, lectins, drugs, vitamins, antibodies, antigens, nucleic acids, DNA and RNA segments, pesticides, dyes and fertilizers. The products may be used for therapeutic or diagnostic applications or bioseparations.
    • 描述了一种生物分子固定方法,其中将生物分子本身或可选地,单体共轭的生物分子用游离单体接枝到已经用电离辐射预照射的亲水性固相聚合物基质上。 在空气中进行预辐射步骤,优选在-78℃下进行,而接枝步骤在基本上无氧的气氛中在0℃下进行。 该技术适用于各种各样的生物分子如酶,催化剂,激素,凝集素,药物,维生素,抗体,抗原,核酸,DNA和RNA片段,农药,染料和化肥的固定。 该产品可用于治疗或诊断应用或生物分离。
    • 58. 发明授权
    • Immobilized biomolecules and method of making same
    • 固定生物分子及其制备方法
    • US4829098A
    • 1989-05-09
    • US876247
    • 1986-06-19
    • Allan S. HoffmanLiang C. Dong
    • Allan S. HoffmanLiang C. Dong
    • C12N11/02G01N33/543G01N33/545
    • C12N11/02G01N33/54393G01N33/545G01N2650/00
    • A method of biomolecule immobilization is described in which the biomolecule itself or, alternatively, a monomer-conjugated biomolecule, is grafted with free monomer onto a hydrophilic, solid-phase, polymeric substrate which has been pre-irradiated with ionizing radiation. The pre-irradiation step is carried out, preferably at -78.degree. C. in air, while the grafting step is carried out at 0.degree. C. in a substantially oxygen-free atmosphere. The technique is applicable to immobilization of a wide variety of biomolecules, such as enzymes, catalysts, hormones, lectins, drugs, vitamins, antibodies, antigens, nucleic acids, DNA and RNA segments, pesticides, dyes and fertilizers. The products may be used for therapeutic or diagnostic applications or bioseparations.
    • 描述了一种生物分子固定方法,其中将生物分子本身或可选地,单体共轭的生物分子用游离单体接枝到已经用电离辐射预照射的亲水性固相聚合物基质上。 在空气中进行预辐射步骤,优选在-78℃下进行,而接枝步骤在基本上无氧的气氛中在0℃下进行。 该技术适用于各种各样的生物分子如酶,催化剂,激素,凝集素,药物,维生素,抗体,抗原,核酸,DNA和RNA片段,农药,染料和化肥的固定。 该产品可用于治疗或诊断应用或生物分离。
    • 60. 发明授权
    • Synthesis of polymers containing integral antibodies
    • 含有整体抗体的聚合物的合成
    • US4609707A
    • 1986-09-02
    • US668248
    • 1984-11-07
    • Robert C. NowinskiAllan S. Hoffman
    • Robert C. NowinskiAllan S. Hoffman
    • C08F290/14G01N33/545C08L89/00C08H1/00
    • C08F290/14G01N33/545G01N2650/00Y10S436/827Y10S530/817
    • A method is disclosed for the de novo synthesis of antibody-containing polymers and the preparation of a class of polymerizable compounds used in the synthesis of such antibody-containing polymers. Antibody-containing polymers formed from monomer/antibody conjugates and nonderivatized polymerizable compounds can be varied in formation of the polymer to provide control of (a) molecular spacing, steric accessibility and the number of antibody molecules that are integrally incorporated into the polymer backbone, and (b) the chemical and physical structure of the polymer itself, thus enabling specific tailoring of antibody-containing polymers for particular end-use application. Also disclosed is a method for the selective removal of a compound from a solution or suspension thereof using monomer/receptor conjugates where the compound has the capacity to bind to the receptor in the conjugate. The bound compound is removed by polymerization - induced separation of the monomer/receptor--compound complex from solution.
    • 公开了用于从含合成抗体的聚合物和制备用于合成这种含抗体聚合物的一类可聚合化合物的方法。 由单体/抗体缀合物和非稀释的可聚合化合物形成的含抗体的聚合物可以在形成聚合物时变化,以提供(a)分子间距,空间可及性和整体并入聚合物主链中的抗体分子的数量的控制,以及 (b)聚合物本身的化学和物理结构,从而能够特异性地定制含抗体的聚合物用于特定的最终应用。 还公开了使用单体/受体共轭物从其溶液或悬浮液中选择性除去化合物的方法,其中化合物具有结合缀合物中受体的能力。 通过聚合诱导分离单体/受体复合物从溶液中除去结合的化合物。